Waters announced the launch of its omniDAWN™ Multi‑Angle Light Scattering (MALS) Photometer, a detector that extends sizing capability from roughly 50 nm to 500 nm in radius. The instrument is designed to work directly with the company’s UPLC systems and columns, enabling a single‑run, multi‑attribute analysis that cuts sample consumption by 30–50 % and solvent use by about 40 %. By combining MALS with ultraviolet and refractive index detection, the platform delivers comprehensive size, composition and heterogeneity data for protein aggregates, viral vectors, lipid nanoparticles and other large biomolecules.
The launch addresses a gap in the industry where traditional MALS instruments are limited to smaller analytes. Large‑molecule characterization is a critical step in biologics development and regulatory compliance, and the extended range of the omniDAWN™ detector positions Waters to capture a growing market for high‑throughput, high‑resolution analysis of advanced therapeutics such as antibody‑drug conjugates and gene‑therapy vectors.
The product’s expanded sizing range and integrated workflow are expected to enhance Waters’ recurring revenue model by broadening its analytical portfolio beyond chromatography and mass spectrometry. The new detector also supports the company’s strategy to provide end‑to‑end solutions for life‑sciences research and quality control, reinforcing its leadership in instrumentation.
Global availability of the omniDAWN™ Photometer is slated for summer 2026, and the instrument will be compatible with Waters’ Empower software later this year. These milestones underscore the company’s commitment to delivering integrated, high‑performance solutions that meet the evolving needs of the biologics and gene‑therapy sectors.
revised_sentiment_rating
}
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.